Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-16

Clinical Trial Update: Vitamin D Supplementation in TB Prevention [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vitamin D supplementation for prevention of latent tuberculosis progression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Harvard School of Public Health (HSPH) | Conditions: Latent Tuberculosis | Phase 3 | Status: COMPLETED